Literature DB >> 9207120

Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.

J van Bergen1, S P Schoenberger, F Verreck, R Amons, R Offringa, F Koning.   

Abstract

The HLA class II-associated invariant chain (Ii)-derived peptide (CLIP) occupies the peptide binding groove during assembly in the endoplasmic reticulum, travels with HLA class II to endosomal compartments, and is subsequently released to allow binding of antigenic peptides. We investigated whether the exchange of CLIP with a known T helper epitope at the DNA level would lead to efficient loading of this helper epitope onto HLA class II. For this purpose, a versatile Ii-encoding expression vector was created in which CLIP can be replaced with a helper epitope of choice. Upon supertransfection of HLA-DR1-transfected 293 cells with an Ii vector encoding a known T helper epitope (HA307-319), predominantly length variants of this epitope were detected in association with the HLA-DR1 molecules of these cells. Moreover, this transfectant was efficiently recognized by a peptide-specific T helper clone (HA1.7). The results suggest that this type of Ii vector can be used to create potent class II+ cellular vaccines in which defined T cell epitopes are continuously synthesized.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207120      PMCID: PMC23850          DOI: 10.1073/pnas.94.14.7499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

Authors:  W M Kast; R Offringa; P J Peters; A C Voordouw; R H Meloen; A J van der Eb; C J Melief
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.

Authors:  S Sanderson; K Frauwirth; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

4.  The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides.

Authors:  I M Freisewinkel; K Schenck; N Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

6.  Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.

Authors:  N Rebai; B Malissen; M Pierres; R S Accolla; G Corte; C Mawas
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

7.  cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure.

Authors:  L Claesson; D Larhammar; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.

Authors:  F A Verreck; D Elferink; C J Vermeulen; R Amons; F Breedveld; R R de Vries; F Koning
Journal:  Tissue Antigens       Date:  1995-04

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures.

Authors:  J Calafat; M Nijenhuis; H Janssen; A Tulp; S Dusseljee; R Wubbolts; J Neefjes
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  9 in total

1.  Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.

Authors:  F Bischof; W Wienhold; C Wirblich; G Malcherek; O Zevering; A M Kruisbeek; A Melms
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

3.  DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.

Authors:  Chien-Fu Hung; Ya-Chea Tsai; Liangmei He; T-C Wu
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

4.  Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain.

Authors:  Toshi Nagata; Taiki Aoshi; Mina Suzuki; Masato Uchijima; Yeung-Hyen Kim; Zhibo Yang; Yukio Koide
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

6.  Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.

Authors:  R F Wang; X Wang; S A Rosenberg
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

7.  Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.

Authors:  Hisse-Martien van Santen; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

8.  Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens.

Authors:  Sandra Rosskopf; Sabrina Jutz; Alina Neunkirchner; Martín R Candia; Beatrice Jahn-Schmid; Barbara Bohle; Winfried F Pickl; Peter Steinberger
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

9.  A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.

Authors:  Katharina Gamerdinger; Corinne Moulon; David R Karp; Jeroen Van Bergen; Frits Koning; Doris Wild; Ulrike Pflugfelder; Hans Ulrich Weltzien
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.